Watch CBS News

Two-Dose Version Of Johnson & Johnson's COVID 19-Vaccine Is 94% Effective

By: KDKA-TV News Staff

PITTSBURGH (KDKA) -- Johnson & Johnson is reporting that a two-dose version of its COVID-19 vaccine provides 94% protection against symptomatic infection.

That makes the two-dose regimen of Johnson & Johnson's vaccine comparable to a two-dose regimen of Moderna or Pfizer's vaccine.

The company is now saying that adding a booster dose to a single shot of the vaccine raised immunity even more -- and should also protect people strongly against infection.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.